Andromeda Surgical
Andromeda Surgical develops autonomous surgical robots combining anatomical mapping and surgeon oversight, initially for prostate enucleation.
$15MSeries A
ParticipantActivity from announced rounds
Techable VC is the investor explicitly named in Andromeda Surgical’s Series A announcement.
Andromeda develops autonomous surgical robots combining anatomical mapping with surgeon oversight, initially for prostate enucleation. The profile retains the issuer-named investor rather than substituting a similarly named fund.
Andromeda Surgical develops autonomous surgical robots combining anatomical mapping and surgeon oversight, initially for prostate enucleation.